tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Catherine Novack, 10 are a BUY (90.91%), 1 are a HOLD (9.09%).
Analyst Catherine Novack, currently employed at JONESTRADING, carries an average stock price target met ratio of 53.33% that have a potential upside of 40.27% achieved within 123 days.
Catherine Novack’s has documented 20 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on WVE, Wave Life Sciences Ltd at 25-Sep-2024.
Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) at 8/9/2024. The price target of $12 was fulfilled within 68 days with a profit of $6.59 (121.81%) receiving and performance score of 17.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$12
$9.01 (301.34%)
$12
28 days ago
(01-Apr-2025)
13/17 (76.47%)
$9.1 (313.79%)
198
Buy
$13
$10.01 (334.78%)
$5
8 months 13 days ago
(16-Aug-2024)
2/3 (66.67%)
$9.43 (264.15%)
149
Hold
$4
8 months 15 days ago
(14-Aug-2024)
1/1 (100%)
$-15.44 (-79.42%)
660
Buy
$3
$0.01 (0.33%)
11 months 14 days ago
(15-May-2024)
2/2 (100%)
$-1.32 (-30.56%)
135
Buy
$2
$-0.99 (-33.11%)
$9
1 years 7 months 30 days ago
(30-Aug-2023)
1/2 (50%)
$-6.52 (-76.53%)
713
What Year was the first public recommendation made by Catherine Novack?
